Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Beam Global (EVSI)
|
Add to portfolio |
|
|
|
| Price: |
$19.55
| | Metrics |
| OS: |
13.9
|
M
| |
-41
|
% ROE
|
| Market cap: |
$272
|
M
| |
-122
|
% ROIC
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
($2.16)
| |
|
|
|
BVPS
|
$3.83
| |
5.11
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 22.0 | 9.0 | 6.2 | 5.1 | 6.2 | 1.4 | 2.8 | 2.6 |
| Revenue growth | 144.3% | 45.0% | 21.5% | -17.1% | 336.4% | -49.2% | 5.3% | 155.7% |
| Cost of goods sold | 23.7 | 10.0 | 6.9 | 5.3 | 6.4 | 4.1 | 2.9 | 2.7 |
| Gross profit | -1.7 | -1.0 | -0.7 | -0.2 | -0.2 | -2.7 | -0.1 | -0.1 |
| Gross margin | -7.6% | -10.8% | -11.4% | -3.0% | -3.1% | -191.2% | -5.2% | -3.0% |
| Selling, general and administrative | 18.0 | 5.6 | 4.5 | 3.1 | 0.0 | 0.0 | 0.0 | 1.6 |
| EBITA | -18.7 | -6.6 | -5.2 | -3.3 | -2.5 | -2.7 | -2.8 | -1.7 |
| EBITA margin | -85.1% | -73.3% | -83.8% | -63.9% | -40.7% | -191.2% | -100.2% | -65.3% |
| Amortization of intangibles | 1.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| EBIT | -19.7 | -6.6 | -5.2 | -3.3 | -2.5 | -2.7 | -2.8 | -1.7 |
| EBIT margin | -89.6% | -73.3% | -83.9% | -64.0% | -40.8% | -191.2% | -100.3% | -65.3% |
| Pre-tax income | -19.7 | -6.6 | -5.2 | -3.9 | -3.6 | -3.0 | -2.6 | -1.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | 0.0% | | | |
| Net income | -19.7 | -6.6 | -5.2 | -3.9 | -3.6 | -3.0 | -2.6 | -1.8 |
| Net margin | -89.5% | -73.3% | -83.9% | -77.0% | -58.4% | -215.4% | -94.7% | -69.6% |
| |
| Diluted EPS | ($1.99) | ($0.74) | ($0.84) | ($0.88) | ($1.24) | ($0.02) | ($0.02) | ($0.02) |
| Shares outstanding (diluted) | 9.9 | 8.9 | 6.2 | 4.5 | 2.9 | 127.5 | 112.5 | 100.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|